NSEShareholders meeting29 Sept 2026 · 29 Sept 2026, 03:37 pm
Shareholders meeting
SMS Pharmaceuticals Limited · SMSPHARMA
✦ AI SummaryResults
SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026. The 38th Annual General Meeting of the Company was held through video conference in compliance with circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI) and other applicable provisions of the Companies Act, 2013.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026
Attachments (1)
📄pdf
Download →
SMSPHARMA_29092026153724_Outcome.pdf
View document text
Date: 29th September, 2026
The Manager, The Manager,
Corporate Filings Department, Listing Compliance Department,
Bombay Stock Exchange Limited, National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block,
Dalal Street, Bandra-Kurla Complex, Bandra (E),
Mumbai- 400 001 Mumbai - 400 051.
Security Code: 532815 Symbol: SMSPHARMA
Sub: Summary of Proceedings of the 38th Annual General Meeting of the Company- Disclosure under
Regulation 30 of the SEBI (LODR) Regulations, 2015
We wish to inform you that the 38th Annual General Meeting (“AGM”) of the Members of the Company
was held today, i.e. Tuesday, 29th September, 2026, through video conference/ other audio-visual means
in compliance with circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of
India (SEBI) and other applicable provisions of the Companies Act, 2013.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
read with Part A of Schedule III thereto, please find enclosed the summary of proceedings of the AGM.
This disclosure will also be hosted on the Company's website www.smspharma.com
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For SMS Pharmaceuticals Limited
Thirumalesh Tumma
Company Secretary
Encl : a/a
SUMMARY OF PROCEEDINGS OF THE 38TH ANNUAL GENERAL MEETING OF
SMS PHARMACEUTICALS LIMITED
The 38th Annual General Meeting (“AGM”) of the Members of SMS Pharmaceuticals Limited (“Company”)
was held today, i.e. Tuesday, 29th September, 2026 at 10:30 a.m. (IST) through video conference (“VC”) /
other audio visual means (“OAVM”) in compliance with the provisions of the Companies Act, 2013 read
with rules made thereunder, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
and applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of
India, from time to time, in this regard.
Mr. Thirumalesh Tumma, Company Secretary & Compliance Officer of the Company welcomed the
Members to the Meeting and briefed them on details relating to their participation at the Meeting
through VC/OAVM.
Mr. Ramesh Babu Potluri, Chairman and Managing Director of the Company, chaired the Meeting.
The Chairman declared that as the requisite quorum being present, the meeting was called to order. As
the Members are not required to physically present, and in line with the circulars issued by the Ministry
of Corporate Affairs and SEBI, the provision for appointing proxies was not applicable.
Following Directors of the Company attended the Meeting through video conference:
Sl. No. Name of the Person Designation Mode of attending the Meeting
1 Mr. Ramesh Babu Chairman & Managing Physically present at the registered
Potluri Director office and participated through VC
2 Mr. Shravan Kudaravalli Independent Director & Physically present at the registered
Chairman of Audit Committee office and participated through VC
3 Mr. Sarvepalli Srinivas Independent Director Participated through VC from
Noida
4 Dr. Suresh Kumar Independent Director Participated through VC from
Gangavarapu Hyderabad
5 Mrs. Shanti Sree Bolleni Independent Director and Participated through VC from
Chairperson of Nomination Hyderabad
and Remuneration Committee
6 Mr. Vamsi Krishna Executive Director Physically present at the registered
Potluri office and participated through VC
7 Dr. Sunkara Venkata Non-Executive Director and Physically present at the registered
Satya Shiva Prasad Chairman of Stakeholder office and participated through VC
Relationship Committee
8 Mr. Trilok Potluri Non-Executive Director Physically present at the registered
office and participated through VC
9 Mr. Lakshmi Narayana Chief Financial Officer Physically present at the registered
Tammineedi office and participated through VC
10 Mr. Thirumalesh Company Secretary Physically present at the registered
Tumma office and participated through VC
Statutory Auditors and Scrutinizer
Sl. No. Name of the Person Particulars Mode of attending the Meeting
1 Mr. V. Nagendra Rao Statutory Auditor M/s. Participated through VC from
Suryanarayana & Suresh Hyderabad
Chartered Accountants
2 Mr. A. Venkateswara Internal Auditor M/s. Physically present at the
Rao Adusumilli and Associates registered office and participated
through VC
3 Mr. C. Sudhir Babu M/s. CSB Associates, Company Physically present at the
Secretaries, Scrutinizer registered office and participated
through VC
It was informed the Members that electronic copy of the Annual Report for FY 2025-26 and Notice
convening the 38th AGM were sent to Members by e-mail on their registered e-mail id.
With the permission of the members, the Notice of the 38th Annual General Meeting was taken as read.
The Chairman expressed his views with respect to the Industry scenario, long term growth, outlook,
performance of the Company, challenges, opportunities going forward and other related matters.
In pursuance of the relevant provisions of Companies Act 2013 read with the SEBI (LODR) Regulations,
2015 as amended from time to time, the Company has provided the E-voting facility by Central Depository
Services (India) Limited (CDSL) to the Shareholders to cast their vote as mentioned in the Notice of the
AGM where the e-voting was kept open from 25th September, 2026 (9.00 a.m.) to 28th September, 2026
(5.00 p.m.). Further the remote e-voting facility was also made available during the AGM for the benefit
of Members who were present during the Meeting and had not cast their votes earlier through remote e-
voting.
The following items of business, as per the Notice convening the 38th AGM of the Company were
transacted at the meeting.
Item No. Agenda Item Type of resolution
Ordinary/ Special
Ordinary Business:
1. Adoption of Audited Standalone and Consolidated Financial Ordinary
Statements of the Company for the Financial Year ended 31st March,
2026, and the reports of the Board of Directors and Auditors
thereon.
2. Declaration of dividend on Equity shares for the financial year 2025- Ordinary
2026
3. Re-appointment of Dr. Sunkara Venkata Satya Shiva Prasad (DIN: Ordinary
10404277) who retires by rotation, and being eligible, offers himself
for re-appointment
Special Business:
4. Approval of material related party transaction(s) with VKT Pharma Ordinary
Private Limited
5. Approval for remuneration payable to the Cost Auditors for the Ordinary
Financial Year 2026-27
6. Approval for Re-appointment of Mr. Ramesh Babu Potluri (DIN: Special
00166381) as Chairman and Managing Director of the Company and
fixation of remuneration
7. Approval to provide loan to SMS Peptides Private Limited, Special
Subsidiary Company
The Chairman then invited the Members to express their views, ask questions and seek clarifications on
the operational and financial performance of the Company on the resolutions set out in the Notice. The
Members were given an opportunity to speak in the order in which they had registered their names. After
giving sufficient time to all Members who wished to speak, the Chairman along with Executive Directors
appropriately responded to the queries raised by them.
The Chairman informed the Members that Mr. C. Sudhir Babu, Practicing Company Secretary
(Membership No; FCS 7666), Proprietor of M/s CSB Associates, Company Secretaries, was the Scrutinizer
appointed by the Board to scrutinize the e-voting process during the meeting and through remote e-
voting, in a fair and transparent manner.
The Chairman authorized Mr. Thirumalesh Tumma, Company Secretary to accept and countersign the
Scrutinizer’s Report and declare the consolidated e-voting results on receipt of the scrutinizer’s report.
He informed the members that the combined results of the remote e-voting as well as
e-voting during the AGM would be announced within two working days form the conclusion of the
Meeting and the results along with the Scrutinizer’s report would be intimated to the S
[Showing first 8,000 characters — download PDF for full document]